mounjaro tirzepatide italia approvazione aifa Nuova guida per farmaci contro diabete e obesità: la risposta degli specialisti del Pederzoli L'Agenzia Italiana del Farmaco (AIFA) ha recentemente pubblicato una nuova guida per l'uso consapevole dei farmaci a Farmaco Mounjaro-Tirzepatide per l'obesità. Cosa

A Clinical Hypothesis on Viral Gastroenteritis and Endogenous Incretin Response A curious observation comes up now and then in clinic: a patient with a viral GI illnesstypically marked by nausea, loss of appetite, and sometimes transient weight lossdescribes symptoms eerily similar to what we see

GLP-1 release and vagal afferent activation mediate the beneficial metabolic and chronotherapeutic effects of D-allulose

Theyre not just any ordinary tablets

Retatrutide is investigational and not FDA-approved

Adalvo announces that it will submit its DCP application for Semaglutide (generic for Ozempic) in February 2026, aligned with the expiry of data exclusivity

Calocurb is not indicated for patients with type 1 diabetes mellitus